Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study

OBJECTIVE: Women with insulin-requiring gestational diabetes mellitus (GDM) are at high risk of developing diabetes within a few years postpartum. We implemented this phase II study to test the hypothesis that vildagliptin, a dipeptidyl peptidase-4 inhibitor, is superior to placebo in terms of reduc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Metab
Asıl Yazarlar: Hummel, Sandra, Beyerlein, Andreas, Pfirrmann, Markus, Hofelich, Anna, Much, Daniela, Hivner, Susanne, Bunk, Melanie, Herbst, Melanie, Peplow, Claudia, Walter, Markus, Kohn, Denise, Hummel, Nadine, Kratzsch, Jürgen, Hummel, Michael, Füchtenbusch, Martin, Hasford, Joerg, Ziegler, Anette-G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869734/
https://ncbi.nlm.nih.gov/pubmed/29396374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2017.12.015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller